comparemela.com
Home
Live Updates
Score2 Trial - Breaking News
Pages:
Latest Breaking News On - Score2 trial - Page 1 : comparemela.com
Bevacizumab First-line Treatment More Cost-Effective in RVO vs Aflibercept
Aflibercept was a less cost-effective treatment for retinal vein occlusion (RVO) compared with bevacizumab, although visual acuity outcomes were similar.
Early treatment diabetic retinopathy study
Macular edema
Anti vegf
Score2 trial
vimarsana © 2020. All Rights Reserved.